Navigation Links
Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024
Date:9/1/2014

nts our analysis on the ADC market for the upcoming decade. It includes detailed drug profiles and likely sales forecast for each of the drug currently in phase II or higher stage of development.

Chapter 6 discusses the current manufacturing challenges associated with ADCs. It also provides information about the leading contract manufacturers which are focused in this domain.

Chapter 7 provides insight to the recent developments and technological advancements. It includes a comprehensive list of partnerships, including the details of agreements, which have taken place between various pharmaceutical companies over the last few years.

Chapter 8 includes profiles of the key companies in the ADC market. Each company profile includes information such as financial performance, geographical presence, marketed / pipeline ADC drugs and recent developments.

Chapter 9 provides our analysis of the strengths, weaknesses, opportunities and threats in the ADC market, capturing the key elements likely to influence future growth.

Chapter 10 is a collection of interview transcripts; these discussions have helped us in forming a better understanding of the key market dynamics, competitive landscape and the likely future trends in the market.

Chapter 11 summarises the overall report. In this chapter, we have provided a recap of the key takeaways and our independent opinion based on the research and analysis described in previous chapters.

Chapter 12 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 13 is an appendix, which lists down all the companies and organisations involved in the ADC market.

TABLE OF CONTENTS
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. The Traditional Treatments: Naked Antibody
'/>"/>

SOURCE Reportlinker
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers
2. Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody for immunotherapy research
3. Telik Receives $1.5 Million National Cancer Institute Contract to Develop Novel Antibody-based PET Imaging Agent for Pancreatic Cancer
4. Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody, a component of Roches immunotherapy assay
5. Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody
6. FDA Grants Orphan Drug Designation for OncoSynergys Investigational Monoclonal Antibody OS2966 in the Treatment of Glioblastoma
7. EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma
8. Synthetic Biologics Academic Collaborator to Present Novel Monoclonal Antibody Combination for Treating Whooping Cough (Pertussis) at Gordon Research Conference
9. Lilly Announces Acquisition of CGRP Antibody for Migraine Prevention from Arteaus Therapeutics
10. arGEN-X Starts Phase Ib Expansion Cohorts With ARGX-110, a Novel Anti-CD70 Antibody, in Cancer Patients
11. BioLineRx and JHL Biotech to Collaborate on Type 1 Diabetes Antibody Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)...  The World MS Day campaign led by the ... awareness of multiple sclerosis and those living with MS ... will move us closer a world free of MS. ... including the National MS Society, have events and planned ... MS Day campaign theme is "access." Whether it is ...
(Date:5/27/2015)...  A special presentation at Digestive Disease Week ... successful experience using  Stretta Therapy  to ... Ronnie Fass , MD, of ... reviewed clinical data on Stretta. Expert panelists then ... Stretta has helped them treat.      Dana ...
(Date:5/27/2015)... Nev. , May 27, 2015  PDL BioPharma, ... John P. McLaughlin , the company,s president and ... Global Healthcare Conference next week in New York City.  ... Wednesday, June 3, 2015 at 11:30 a.m. EDT. ... of the presentation, go to the Company,s website at ...
Breaking Medicine Technology:People Around The World Are Sharing What Makes Them Stronger Than Multiple Sclerosis 2People Around The World Are Sharing What Makes Them Stronger Than Multiple Sclerosis 3People Around The World Are Sharing What Makes Them Stronger Than Multiple Sclerosis 4People Around The World Are Sharing What Makes Them Stronger Than Multiple Sclerosis 5DDW Presentation Examines Stretta As A Versatile And Effective GERD Treatment For Multiple Patient Populations 2DDW Presentation Examines Stretta As A Versatile And Effective GERD Treatment For Multiple Patient Populations 3PDL BioPharma to Present at Jefferies 2015 Global Healthcare Conference 2
... Agendia, a commercial-stage molecular cancer diagnostics ... Breast Cancer Conference (2011) Expert Panel,s recommendations highlight the ... particular biological subtype of their tumor - in guiding ... panel, "it is no longer tenable to consider breast ...
... -- Winner Medical Group Inc. (Nasdaq: WWIN ; "Winner ... disposables and non-woven fabric made from 100% natural PurCotton® products in ... June 30, 2011. Fiscal Third ... (in millions of USD, except per share data)Q3 , FY2011 ...
Cached Medicine Technology:International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment 2International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment 3Winner Medical Reports Third Quarter Fiscal 2011 Results 2Winner Medical Reports Third Quarter Fiscal 2011 Results 3Winner Medical Reports Third Quarter Fiscal 2011 Results 4Winner Medical Reports Third Quarter Fiscal 2011 Results 5Winner Medical Reports Third Quarter Fiscal 2011 Results 6Winner Medical Reports Third Quarter Fiscal 2011 Results 7Winner Medical Reports Third Quarter Fiscal 2011 Results 8Winner Medical Reports Third Quarter Fiscal 2011 Results 9Winner Medical Reports Third Quarter Fiscal 2011 Results 10Winner Medical Reports Third Quarter Fiscal 2011 Results 11Winner Medical Reports Third Quarter Fiscal 2011 Results 12Winner Medical Reports Third Quarter Fiscal 2011 Results 13Winner Medical Reports Third Quarter Fiscal 2011 Results 14Winner Medical Reports Third Quarter Fiscal 2011 Results 15
(Date:5/27/2015)... CompanionDx announced that its ... analysis in personalized cancer therapy: Non-small cell lung cancer ... of Clinical Oncology (ASCO) as part of their annual ... The molecular and clinical data used for the study ... The study reports improved patient outcomes from a preliminary ...
(Date:5/27/2015)... On June 5, Plan B [the ... with LifeSource to host Donate Your Break, a public ... a LifeSource donor coach outside of 116 W. Illinois ... Demand for whole blood units is highest for LifeSource, ... months. LifeSource requires approximately 1,000 donations per day to ...
(Date:5/27/2015)... Texas (PRWEB) May 27, 2015 ... the current state of the Omega-3 industry. The ... including definitions, classifications, applications and industry chain structure. ... international markets including development trends, competitive landscape analysis, ... Gc Rieber Oils, Camanchaca Fishing Company, Seadragon Marine ...
(Date:5/27/2015)... 2015 SonarMD, LLC, recently ... a first-of-its kind, cloud-based algorithmic process for ... chronic gastrointestinal disease. , Developed by noted ... allows physicians to monitor their patients’ health ... of electronic health assessment surveys. Using nationally ...
(Date:5/27/2015)... MD (PRWEB) May 27, 2015 “Heroin has ... that’s where our overdoses are coming from,” says Harford County ... on May 8th. In the surging heroin related incidents ... pushing for prevention education to prevent heroin addiction and subsequent ... a possession charge. Drug Rehab Baltimore is a drug and ...
Breaking Medicine News(10 mins):Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 3Health News:Donate Your Break and Save Lives at the River North Blood Drive 2Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 3
... THIN CHILDREN MAY HAVE POORER LUNG FUNCTION ,A ... through midlife may be influenced by several factors, including birth ... United Kingdom analyzed health data from 252 patients, all aged ... the patients at age 49 to 51. Results showed that ...
... A minimally invasive surgical approach developed by head ... of Medicine has been cleared by the U.S. Food ... (Intuitive Surgical, Inc., Sunnyvale, California) has been cleared for ... select malignant tumors in adults. Drs. Gregory S. ...
... Energy and Commerce as part of an investigation into preventable ... report recommending further restrictions regarding duty hours for resident physicians ... safety, according to an article published in the January issue ... (JACR). In 2003, the Accreditation Council for ...
... sexual arousal, whereas in men, the responses of the ... other, according to Assistant Professor Meredith Chivers, from Queen,s ... Seto, Martin Lalumire, Ellen Laan, and Teresa Grimbos. Their ... and physiological measures of sexual arousal in men and ...
... osteoarthritis (OA) accounts for more disability in the elderly than ... other health benefits, can increase stresses on the joints of ... issue of PM&R: The journal of injury, function and ... ankle joint motions of running barefoot versus running in modern ...
... researchers halted the growth of blood vessels that tumors ... in the Journal of Experimental Medicine ( ... its effects on neuronal growth, the team found that ... human blood vessels. By diminishing {delta}-catenin expression, the team ...
Cached Medicine News:Health News:News briefs from the January issue of Chest 2Health News:FDA clears TransOral robotic surgery developed at Penn 2Health News:FDA clears TransOral robotic surgery developed at Penn 3Health News:Institute of Medicine recommends stricter resident duty hour regulations to prevent medical errors 2Health News:Women's bodies and minds agree less than men's on what's sexy 2Health News:Running shoes may cause damage to knees, hips and ankles 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: